Ideagen PLC Exercise of Options and Total Voting Rights (0115S)

TIDMIDEA

RNS Number : 0115S

Ideagen PLC

27 September 2017

Ideagen PLC

("Ideagen," "the Company" or the "Group")

Exercise of Options and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted 150,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of share options by an employee.

Application has been made to the London Stock Exchange for the 150,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 3 October 2017.

After Admission, the total number of Ordinary Shares in issue will be 198,901,414 and the total number of voting rights will therefore be 198,901,414. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 
Ideagen plc                      01629 699100 
David Hornsby, Chief Executive 
Graeme Spenceley, Finance 
 Director 
 
finnCap Limited                  020 7220 0500 
Stuart Andrews/Henrik 
 Persson/James Thompson 
 (Nomad) 
Stephen Norcross (Corporate 
 Broking) 
 
 
 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFFEADIDFID

(END) Dow Jones Newswires

September 27, 2017 11:28 ET (15:28 GMT)